Efficacy of In-Ovo Vaccination against Marek's Disease in Commercial Broiler

마렉백신의 In-Ovo 접종에 따른 육계에서의 효능 평가

  • Um, H.J. (College of Veterinary Medicine and Research Institute of Veterinary, Chungbuk National University) ;
  • Won, M.Y. (College of Veterinary Medicine and Research Institute of Veterinary, Chungbuk National University) ;
  • Lee, D.W. (Medicine, Merial Korea) ;
  • Go, D.W. (CherryBro Co. Ltd.) ;
  • Mo, I.P. (College of Veterinary Medicine and Research Institute of Veterinary, Chungbuk National University)
  • 엄현정 (충북대학교 수의과대학 및 동물의학연구소) ;
  • 원미영 (충북대학교 수의과대학 및 동물의학연구소) ;
  • 이동우 (메리알코리아) ;
  • 고도욱 (체리부로㈜) ;
  • 모인필 (충북대학교 수의과대학 및 동물의학연구소)
  • Published : 2006.12.30

Abstract

This study has been designed to evaluate the efficacy of MD in-ovo vaccination in broiler and to find the contamination level of MD virus in broiler farms. A nested PCR test was used to find the level of filed contamination of pathogenic MD virus in the commercial broiler farms. The positive rate of farms contaminated with pathogenic MD virus was 26.09%. And to evaluate the efficacy of MD vaccination, performance factors such as the mortality, feed conversion rate and body weight at market age has been recorded and compared among farms. There was no difference on these factors between vaccinated and non-vaccinated farms except performance. We need further investigation of the film with low performance index. The B/B ratio, which is common index for the evaluation of bursal changes, was calculated and compared between vaccinated and non-vaccinated group There were significant decreases of B/B ratio in the both group without any statistical difference between groups. The reason of decreased bursal size may be due to other infection such as IBD. From this study, we can know that the contamination rate of fm with pathogenic MD virus was very low and not different from previous study. However, the difference of the contamination rate in different locations recommends periodical monitoring on these areas.

본 실험은 육계에서의 Marek's disease(MD) 백신에 대한 안전성과 효용성을 국내에 기 도입된 18일령 계란에서의 백신 접종 방법(In-Ovo vaccination)을 이용하여 평가하고자 실시하였다. 육계에서의 MD 오염율은 nested PCR을 이용하였으며 백신 접종군과 비접종군간의 생산성 차이를 출하 일령, 평균출하체중, 출하율, 사료 효율을 기본으로 하는 생산 지수를 측정하여 비교하였다. 백신에 의한 면역 억제 현상을 파악하기 위하여 접종 농장에서 채취한 혈청에서의 항체 역가수준과 F낭의 무게 변화를 검사하였다. 국내 육계에서의 MD 발생율을 파악하기 위하여 nested PCR을 실시한 결과 조사 대상 농장 중 26.09%가 오염되었으며, 백신 접종 농장과 비접종 농장간의 생산 지수의 차이는 통계학적으로 유의한 차이가 없었다. 그러나 MDV 오염군에서의 MD 백신 접종 농장의 생산 지수가 비접종 농장보다 높아 간접적으로 효과가 있음이 인정되었다. 면역 억제여부를 파악하기 위한 검사에서는 두 그룹 간 B/B ratio 차이는 없었으나 두 계군 모두 출하 시 심한 위축을 보여주어 혈청 검사 성적과 연계하여 볼 때 국내 육계 농장에서의 IBD 감염이 만연되어 있다는 것을 알 수 있었다. 본 연구를 통해서 국내 육계에서의 MDV 오염율이 파악되었으며, In-Ovo 백신 접종에 의한 MD 백신 접종은 안전성에 있어서는 별다른 문제가 없었으나 효능면에 있어서는 MD 야외감염율이 낮고 IBD와 같은 면역 억제 질병의 감염이 만연되어 있어 정확한 평가가 되지 않아 앞으로 후속 연구가 진행되어야 할 것으로 판단되었다.

Keywords

References

  1. Alexander DJ 1997 Newcastle disease and other avian Paramyxoviridae infections. In Diseases of poultry (Calnek BW, Barnes HJ, Beard CW, Mcdougald LR and Saif YM eds.), pp. 541-569, 10 th ed., Iowa State University Press, Ames, IA
  2. Alexander DJ 1998 Newcastle disease virus and other Paramyxoviruses. In A laboratory manual for the isolation andidentification of avian pathogens, (Swayne DE, Gilsson JR, Jackwood MW, Pearson JE and Reed WM eds.) pp. 156-163. 4th ed. American Association of Avian Pathologist, Kennett Square, PA
  3. Balamurugan V, Kataria JM 2006 Economically important nononcogenic immunosuppressive viral diseases of chicken current status. Vet Res Commun 30:541-566 https://doi.org/10.1007/s11259-006-3278-4
  4. Finkelman FD, Shea-Donohue T, Godhill J, Sulivan CA, Morris SC, Madden KB, Gause WC, Urban JF 1997 Cytokines regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models. Annu rev Immunol 15: 505-533 https://doi.org/10.1146/annurev.immunol.15.1.505
  5. Islam A, Harrison B, Cheetham BE, Mahony TJ, Young PL, Walkden-Brown SW 2004 Differential amplification and quantitation of Marek's disease viruses using real-time polymerase chain reaction. J Virol Metholds 119:103-113 https://doi.org/10.1016/j.jviromet.2004.03.006
  6. Sharma JM, Lee LF, Wakenell PS 1984 Comparative viral, immunologic and pathologic responses of chickens inoculated with herpesvirus of turkeys as embryos or at hatch. Am J Vet Res 45: 1619-1623
  7. Sharma JM, Zhang Y, Jensen D, Silke R, Yeh HY 2002 Field trial in commercial broilers with a multivalent in ovo vaccine comprising a mixture of live viral vaccines against Marek's disease, infectious bursal disease, Newcastle disease, and fowl pox. Avian Dis 46: 613-622 https://doi.org/10.1637/0005-2086(2002)046[0613:FTICBW]2.0.CO;2
  8. Sung HW 2000 Recent increase of Marek's disease in Korea related to the virulence increase of the virus. Avian Dis 46: 517-524 https://doi.org/10.1637/0005-2086(2002)046[0517:RIOMSD]2.0.CO;2
  9. Witter RL 1983 Characteristics of Marek's disease virusesisolated from vaccinated commercial chicken flocks : association of viral pathotype with lymphoma frequency. Avian Dis 27: 113-132 https://doi.org/10.2307/1590377
  10. Witter RL 1997 Increased virulence of Marek's disease virus field isolates. Avian Dis 41:149-163 https://doi.org/10.2307/1592455
  11. Witter RL 1998 Control strategies for Marek's disease : a perspective for the future. Poult Sci 77:1197-1203 https://doi.org/10.1093/ps/77.8.1197